John Powell, N.P

NPI: 1194725432
Total Payments
$4,083
2024 Payments
$1,507
Companies
47
Transactions
203
Medicare Patients
427
Medicare Billing
$29,970

Payment Breakdown by Category

Food & Beverage$4,041 (99.0%)
Education$41.19 (1.0%)
Other$0.00 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $4,041 201 99.0%
Education $41.19 2 1.0%

Top Paying Companies

Company Total Records Latest Year
Merck Sharp & Dohme LLC $438.36 19 $0 (2024)
Janssen Biotech, Inc. $295.62 13 $0 (2024)
Pharmacyclics LLC, An AbbVie Company $266.20 15 $0 (2023)
Lilly USA, LLC $251.20 11 $0 (2024)
Novartis Pharmaceuticals Corporation $249.34 13 $0 (2024)
Gilead Sciences, Inc. $243.22 7 $0 (2024)
AstraZeneca Pharmaceuticals LP $212.19 12 $0 (2024)
Eisai Inc. $171.59 9 $0 (2024)
GlaxoSmithKline, LLC. $140.67 7 $0 (2024)
Daiichi Sankyo Inc. $120.19 7 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $1,507 72 Gilead Sciences, Inc. ($182.84)
2023 $2,134 105 Merck Sharp & Dohme LLC ($278.42)
2022 $392.08 22 Pharmacyclics LLC, an AbbVie Company ($136.19)
2021 $49.49 4 Janssen Biotech, Inc. ($13.71)

All Payment Transactions

203 individual payment records from CMS Open Payments — Page 1 of 9

Date Company Product Nature Form Amount Type
07/12/2024 ABBVIE INC. IMBRUVICA (Drug) Food and Beverage In-kind items and services $23.22 General
Category: ONCOLOGY
06/26/2024 E.R. Squibb & Sons, L.L.C. OPDIVO (Biological) Food and Beverage Cash or cash equivalent $16.85 General
Category: Oncology
06/17/2024 Eisai Inc. Lenvima (Drug) Food and Beverage In-kind items and services $17.15 General
Category: Oncology
06/13/2024 Merck Sharp & Dohme LLC REBLOZYL (Biological) Food and Beverage In-kind items and services $25.17 General
Category: HEMATOLOGY
06/12/2024 Novartis Pharmaceuticals Corporation PLUVICTO (Drug) Food and Beverage In-kind items and services $18.39 General
Category: Oncology
06/11/2024 Rigel Pharmaceuticals, Inc. Rezlidhia (Drug), Tavalisse Food and Beverage Cash or cash equivalent $16.45 General
Category: Acute Myeloid Leukemia
06/10/2024 Takeda Pharmaceuticals U.S.A., Inc. NINLARO (Drug) Food and Beverage In-kind items and services $20.83 General
Category: ONCOLOGY
06/06/2024 Eisai Inc. Lenvima (Drug) Food and Beverage In-kind items and services $20.78 General
Category: Oncology
06/06/2024 AstraZeneca Pharmaceuticals LP ENHERTU (Biological) Food and Beverage In-kind items and services $18.51 General
Category: Oncology
06/05/2024 ABBVIE INC. IMBRUVICA (Drug) Food and Beverage In-kind items and services $22.29 General
Category: ONCOLOGY
06/05/2024 Merck Sharp & Dohme LLC KEYTRUDA (Biological) Food and Beverage In-kind items and services $19.16 General
Category: ONCOLOGY
06/03/2024 SERVIER PHARMACEUTICALS LLC Tibsovo (Drug) Food and Beverage In-kind items and services $18.63 General
Category: Oncology
05/23/2024 PharmaEssentia USA Corporation BESREMI (Drug) Food and Beverage In-kind items and services $15.81 General
Category: Oncology
05/22/2024 Lilly USA, LLC VERZENIO (Drug), JAYPIRCA Food and Beverage In-kind items and services $24.88 General
Category: Oncology
05/18/2024 Gilead Sciences, Inc. Food and Beverage In-kind items and services $27.08 General
05/18/2024 Janssen Biotech, Inc. RYBREVANT (Drug) Food and Beverage In-kind items and services $19.57 General
Category: Oncology
05/17/2024 GlaxoSmithKline, LLC. OJJAARA (Drug) Food and Beverage In-kind items and services $16.39 General
Category: ONCOLOGY
05/15/2024 Exelixis Inc. CABOMETYX (Drug) Food and Beverage In-kind items and services $18.22 General
Category: Renal Cell Carcinoma (RCC) Hepatocellular Carcinoma (HCC) Differentiated Thyroid Cancer (DTC)
05/13/2024 Janssen Biotech, Inc. TECVAYLI (Biological), TALVEY Food and Beverage In-kind items and services $13.90 General
Category: Oncology
05/09/2024 Celgene Corporation REBLOZYL (Biological) Food and Beverage Cash or cash equivalent $27.28 General
Category: Hematology
05/08/2024 Daiichi Sankyo Inc. Enhertu (Drug) Food and Beverage In-kind items and services $16.62 General
Category: ONCOLOGY
04/30/2024 Merck Sharp & Dohme LLC KEYTRUDA (Biological) Food and Beverage In-kind items and services $28.88 General
Category: ONCOLOGY
04/28/2024 Daiichi Sankyo Inc. INJECTAFER (Drug) Food and Beverage In-kind items and services $26.29 General
Category: Iron Deficiency Anemia
04/26/2024 Merck Sharp & Dohme LLC KEYTRUDA (Biological) Food and Beverage In-kind items and services $19.38 General
Category: ONCOLOGY
04/25/2024 Mirati Therapeutics, Inc. KRAZATI (Drug) Food and Beverage Cash or cash equivalent $15.84 General
Category: Oncology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 4 252 309 $79,817 $14,357
2022 2 45 104 $26,584 $4,990
2021 3 46 61 $18,231 $3,651
2020 2 84 117 $28,325 $6,971
Total Patients
427
Total Services
591
Medicare Billing
$29,970
Procedure Codes
11

All Medicare Procedures & Services

11 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99213 Established patient office or other outpatient visit, 20-29 minutes Facility 2023 130 167 $34,431 $6,583 19.1%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2023 84 104 $32,919 $6,151 18.7%
99203 New patient office or other outpatient visit, 30-44 minutes Facility 2023 27 27 $10,015 $1,399 14.0%
G0296 Counseling visit to discuss need for lung cancer screening using low dose ct scan (ldct) (service is for eligibility determination and shared decision making) Facility 2023 11 11 $2,452 $223.41 9.1%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2022 26 57 $17,298 $3,172 18.3%
99213 Established patient office or other outpatient visit, 20-29 minutes Facility 2022 19 47 $9,286 $1,818 19.6%
99214 Established patient outpatient visit, total time 30-39 minutes Facility 2021 22 33 $9,654 $1,985 20.6%
99204 New patient outpatient visit, total time 45-59 minutes Facility 2021 11 11 $5,335 $926.51 17.4%
99213 Established patient outpatient visit, total time 20-29 minutes Facility 2021 13 17 $3,242 $739.84 22.8%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 54 80 $20,000 $5,269 26.3%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 30 37 $8,325 $1,702 20.4%

About John Powell, N.P

John Powell, N.P is a Family healthcare provider based in Memphis, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/28/2005. The National Provider Identifier (NPI) number assigned to this provider is 1194725432.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, John Powell, N.P has received a total of $4,083 in payments from pharmaceutical and medical device companies, with $1,507 received in 2024. These payments were reported across 203 transactions from 47 companies. The most common payment nature is "Food and Beverage" ($4,041).

As a Medicare-enrolled provider, Powell has provided services to 427 Medicare beneficiaries, totaling 591 services with total Medicare billing of $29,970. Data is available for 4 years (2020–2023), covering 11 distinct procedure/service records.

Practice Information

  • Specialty Family
  • Other Specialties Family, Family
  • Location Memphis, TN
  • Active Since 07/28/2005
  • Last Updated 06/22/2021
  • Taxonomy Code 363LF0000X
  • Entity Type Individual
  • NPI Number 1194725432

Products in Payments

  • IMBRUVICA (Drug) $384.86
  • KEYTRUDA (Biological) $344.06
  • ENHERTU (Biological) $174.60
  • Lenvima (Drug) $171.59
  • DARZALEX (Biological) $163.55
  • Trodelvy (Drug) $136.84
  • CABOMETYX (Drug) $108.94
  • REBLOZYL (Biological) $101.27
  • LONSURF (Drug) $98.93
  • VERZENIO (Drug) $92.75
  • RETEVMO (Drug) $87.78
  • PYRUKYND (Drug) $87.13
  • INJECTAFER (Drug) $86.42
  • KISQALI (Drug) $80.65
  • Rezlidhia (Drug) $72.83
  • JAYPIRCA (Drug) $70.67
  • XTANDI (Drug) $68.23
  • JEMPERLI (Biological) $65.54
  • AYVAKIT (Drug) $65.39
  • ZEJULA (Drug) $58.74

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Family Doctors in Memphis